ArticleCase reports in oncology

Sequential Multiple-Organ Immune-Related Adverse Events during and after Pembrolizumab Therapy in Triple-Negative Breast Cancer: A Case Report.

Sae Imada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.